Etilefrine
CARDIOVASCULAR SYSTEM
Also known as: dl-Etilefrin, ethyl adrianol, ethylphenylephrine, etiladrianol, etilefrin, etilefrine HCl, etilefrine hydrochloride, N-Ethylnorphenylephrine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Etilefrine is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1929. DrugCentral lists 1 molecular target, including ADRB1.
- Molecular targets: ADRB1 (1 listed in DrugCentral).
- ATC code: C01CA01 (Adrenergic and dopaminergic agents).
- Molecular formula: C10H15NO2; molecular weight 181.24 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Beta-1 adrenergic receptor | ADRB1 | agonist | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1929-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C01CA01 | CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES › Adrenergic and dopaminergic agents |
C01CA51 | CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES › Adrenergic and dopaminergic agents |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Cafe au lait spots | 50.9 |
| Sulphaemoglobinaemia | 50.5 |
| Anal stenosis | 49.8 |
| Wolff-Parkinson-White syndrome | 45.9 |
| Kidney duplex | 45.7 |
| Ear malformation | 44.4 |
| Pulmonary valve stenosis | 42.6 |
| Motor developmental delay | 42.6 |
| Phimosis | 42.4 |
| Postoperative adhesion | 42.3 |
| Dacryostenosis acquired | 42.2 |
| Sepsis neonatal | 41.5 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Etilefrine is on its molecule page.
| Molecular formula | C10H15NO2 |
|---|---|
| Molecular weight | 181.24 g/mol |
| CAS number | 709-55-7 |
| InChIKey | SQVIAVUSQAWMKL-UHFFFAOYSA-N |
| PubChem CID | 3306 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Etilefrine work?
Its molecular targets in DrugCentral include ADRB1 (agonist).
When was Etilefrine first approved?
Etilefrine was first approved by the YEAR INTRODUCED in 1929.
What is the chemical formula of Etilefrine?
Etilefrine has the molecular formula C10H15NO2 and a molecular weight of 181.24 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1101 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL86882 — compound record and bioactivity
- PubChem CID 3306 — chemical identifiers
- DrugBank DB08985 — drug record
- FDA UNII ZB6F8MY53V — substance identity
- UniProt P08588 (ADRB1) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.